Takahiro Soda

Takahiro Soda

Auto-generated profile, based on publicly available information

Takahiro Soda

Department of Psychiatry University of Florida Gainesville Florida USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Cell
Verified
Journal Article
Closed access
YMYingwei Mao
Yingwei Mao
XGXuecai Ge
Xuecai Ge
CFChristopher L. Frank
Christopher L. Frank
JMJon M. Madison
Jon M. Madison
AKAngela N. Koehler
Angela N. Koehler
LTLi-Huei Tsai
Li-Huei Tsai

3 May 2015 in Brain
Verified
Journal Article
Open access
PDF file
JWJason J. Wolff
Jason J. Wolff
GGGuido Gerig
Guido Gerig
JLJohn D. Lewis
John D. Lewis
TSTakahiro Soda
Takahiro Soda
MSMartin A. Styner
Martin A. Styner
FNFor The Ibis Network
For The Ibis Network
Numerous brain imaging studies indicate that the corpus callosum is smaller in older children and adults with autism spectrum disorder. However, there are no published studies examining the morphological development of this connective pathway in infants at-risk for the disorder. Magnetic resonance imaging data were collected from 270 infants at high familial risk for autism spectrum disorder and 108 low-risk controls at 6, 12 and 24 months of age, with 83% of infants contributing two or more data points. Fifty-seven children met criteria for ASD based on clinical-best estimate diagnosis at age 2 years. Corpora callosa were measured for area, length and thickness by automated segmentation. We found significantly increased corpus callosum area and thickness in children with autism spectrum disorder starting at 6 months of age. These differences were particularly robust in the anterior corpus callosum at the 6 and 12 month time points. Regression analysis indicated that radial diffusivity in this region, measured by diffusion tensor imaging, inversely predicted thickness. Measures of area and thickness in the first year of life were correlated with repetitive behaviours at age 2 years. In contrast to work from older children and adults, our findings suggest that the corpus callosum may be larger in infants who go on to develop autism spectrum disorder. This result was apparent with or without adjustment for total brain volume. Although we did not see a significant interaction between group and age, cross-sectional data indicated that area and thickness differences diminish by age 2 years. Regression data incorporating diffusion tensor imaging suggest that microstructural properties of callosal white matter, which includes myelination and axon composition, may explain group differences in morphology.

10 June 2012 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
FAFroylan Calderon de Anda
Froylan Calderon de Anda
ARAna Lucia Rosario
Ana Lucia Rosario
ODOmer Durak
Omer Durak
TTTracy Tran
Tracy Tran
JGJohannes Gräff
Johannes Gräff
LTLi-Huei Tsai
Li-Huei Tsai

25 October 2004 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
CCCarlos Cepeda
Carlos Cepeda
ASAmaal J. Starling
Amaal J. Starling
NWNanping Wu
Nanping Wu
ONOanh K. Nguyen
Oanh K. Nguyen
BUBesim Uzgil
Besim Uzgil
MLMichael Levine
Michael Levine

16 April 2013 in Molecular Psychiatry
Verified
Journal Article
Open access
TST Soda
T Soda
CFC Frank
C Frank
KIK Ishizuka
K Ishizuka
ABA Baccarella
A Baccarella
YPY-U Park
Y-U Park
LTL-H Tsai
L-H Tsai
Disrupted-In-Schizophrenia 1 (DISC1), a risk factor for major mental illnesses, has been studied extensively in the context of neurodevelopment. However, the role of DISC1 in neuronal signaling, particularly in conjunction with intracellular cascades that occur in response to dopamine, a neurotransmitter implicated in numerous psychiatric disorders, remains elusive. Previous data suggest that DISC1 interacts with numerous proteins that impact neuronal function, including activating transcription factor 4 (ATF4). In this study, we identify a novel DISC1 and ATF4 binding region in the genomic locus of phosphodiesterase 4D (PDE4D), a gene implicated in psychiatric disorders. We found that the loss of function of either DISC1 or ATF4 increases PDE4D9 transcription, and that the association of DISC1 with the PDE4D9 locus requires ATF4. We also show that PDE4D9 is increased by D1-type dopamine receptor dopaminergic stimulation. We demonstrate that the mechanism for this increase is due to DISC1 dissociation from the PDE4D locus in mouse brain. We further characterize the interaction of DISC1 with ATF4 to show that it is regulated via protein kinase A-mediated phosphorylation of DISC1 serine-58. Our results suggest that the release of DISC1-mediated transcriptional repression of PDE4D9 acts as feedback inhibition to regulate dopaminergic signaling. Furthermore, as DISC1 loss-of-function leads to a specific increase in PDE4D9, PDE4D9 itself may represent an attractive target for therapeutic approaches in psychiatric disorders.

21 July 2021 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
NSNora I. Strom
Nora I. Strom
TSTakahiro Soda
Takahiro Soda
CMCarol A. Mathews
Carol A. Mathews
LDLea K. Davis
Lea K. Davis
This review covers recent findings in the genomics of obsessive-compulsive disorder (OCD), obsessive-compulsive symptoms, and related traits from a dimensional perspective. We focus on discoveries stemming from technical and methodological advances of the past five years and present a synthesis of human genomics research on OCD. On balance, reviewed studies demonstrate that OCD is a dimensional trait with a highly polygenic architecture and genetic correlations to multiple, often comorbid psychiatric phenotypes. We discuss the phenotypic and genetic findings of these studies in the context of the dimensional framework, relying on a continuous phenotype definition, and contrast these observations with discoveries based on a categorical diagnostic framework, relying on a dichotomous case/control definition. Finally, we highlight gaps in knowledge and new directions for OCD genetics research.